BIOEN Stock Overview
Biotrend Cevre Ve Enerji Yatirimlari Anonim Sirketi engages in the solid waste management and energy production activities in Turkey.
Biotrend Cevre ve Enerji Yatirimlari Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₺7.34|
|52 Week High||₺12.54|
|52 Week Low||₺4.68|
|1 Month Change||26.77%|
|3 Month Change||33.94%|
|1 Year Change||22.76%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||41.02%|
Recent News & Updates
|BIOEN||TR Renewable Energy||TR Market|
Return vs Industry: BIOEN underperformed the TR Renewable Energy industry which returned 128.6% over the past year.
Return vs Market: BIOEN underperformed the TR Market which returned 61.2% over the past year.
|BIOEN Average Weekly Movement||4.7%|
|Renewable Energy Industry Average Movement||5.8%|
|Market Average Movement||5.9%|
|10% most volatile stocks in TR Market||8.7%|
|10% least volatile stocks in TR Market||4.1%|
Stable Share Price: BIOEN is less volatile than 75% of TR stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: BIOEN's weekly volatility (5%) has been stable over the past year.
About the Company
Biotrend Cevre Ve Enerji Yatirimlari Anonim Sirketi engages in the solid waste management and energy production activities in Turkey. It operates biogas and biomass facilities with an installed power capacity of 55,781 MWe. The company was founded in 2017 and is based in Istanbul, Turkey.
Biotrend Cevre ve Enerji Yatirimlari Fundamentals Summary
|BIOEN fundamental statistics|
Is BIOEN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BIOEN income statement (TTM)|
|Cost of Revenue||₺422.57m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.014|
|Net Profit Margin||1.14%|
How did BIOEN perform over the long term?See historical performance and comparison
Is BIOEN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BIOEN?
Other financial metrics that can be useful for relative valuation.
|What is BIOEN's n/a Ratio?|
Price to Sales Ratio vs Peers
How does BIOEN's PS Ratio compare to its peers?
|BIOEN PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
Price-To-Sales vs Peers: BIOEN is good value based on its Price-To-Sales Ratio (6.1x) compared to the peer average (72x).
Price to Earnings Ratio vs Industry
How does BIOEN's PE Ratio compare vs other companies in the Renewable Energy Industry?
Price-To-Sales vs Industry: BIOEN is expensive based on its Price-To-Sales Ratio (6.1x) compared to the TR Renewable Energy industry average (6x)
Price to Sales Ratio vs Fair Ratio
What is BIOEN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||6.1x|
|Fair PS Ratio||n/a|
Price-To-Sales vs Fair Ratio: Insufficient data to calculate BIOEN's Price-To-Sales Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of BIOEN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate BIOEN's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate BIOEN's fair value for valuation analysis.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BIOEN's PEG Ratio to determine if it is good value.
Discover undervalued companies
How is Biotrend Cevre ve Enerji Yatirimlari forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Utilities industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Biotrend Cevre ve Enerji Yatirimlari has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
How has Biotrend Cevre ve Enerji Yatirimlari performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BIOEN has a high level of non-cash earnings.
Growing Profit Margin: BIOEN's current net profit margins (1.1%) are lower than last year (15.2%).
Past Earnings Growth Analysis
Earnings Trend: BIOEN's earnings have grown significantly by 30.3% per year over the past 5 years.
Accelerating Growth: BIOEN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BIOEN had negative earnings growth (-83%) over the past year, making it difficult to compare to the Renewable Energy industry average (47.7%).
Return on Equity
High ROE: BIOEN's Return on Equity (0.5%) is considered low.
Discover strong past performing companies
How is Biotrend Cevre ve Enerji Yatirimlari's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: BIOEN's short term assets (TRY676.2M) exceed its short term liabilities (TRY541.0M).
Long Term Liabilities: BIOEN's short term assets (TRY676.2M) do not cover its long term liabilities (TRY845.8M).
Debt to Equity History and Analysis
Debt Level: BIOEN's net debt to equity ratio (158%) is considered high.
Reducing Debt: Insufficient data to determine if BIOEN's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: BIOEN's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: BIOEN's interest payments on its debt are well covered by EBIT (6.8x coverage).
Discover healthy companies
What is Biotrend Cevre ve Enerji Yatirimlari current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate BIOEN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BIOEN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if BIOEN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BIOEN's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BIOEN has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Biotrend Cevre ve Enerji Yatirimlari has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Biotrend Cevre ve Enerji Yatirimlari A.S.'s employee growth, exchange listings and data sources
- Name: Biotrend Cevre ve Enerji Yatirimlari A.S.
- Ticker: BIOEN
- Exchange: IBSE
- Founded: 2017
- Industry: Renewable Electricity
- Sector: Utilities
- Implied Market Cap: ₺3.670b
- Shares outstanding: 500.00m
- Website: https://www.biotrendenerji.com.tr
Number of Employees
- Biotrend Cevre ve Enerji Yatirimlari A.S.
- Ekinciler Caddesi
- Erturk Sokak 3
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/26 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.